AssayIndex
Reports by quarter

Reports submitted in 2026-Q2 · page 23

Buyer-sourced sensitivity analysis added to every supplier scorecard. Median purity for the quarter is 99.00 % area, n=1126. Read the 2026-Q2 state-of-the-index report →

1,126 records29 pagesmedian on this page 98.97 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043133BPC-157SSASSA-2601-N6863Janoshik2026-Q298.374.34106.6Supplier-supplied1MARGINAL
AX-2026-042841SurvodutideGGPepsGGPE-2512-Y2660Janoshik2026-Q297.713.99—Buyer-sourced2MARGINAL
AX-2026-042804RetatrutideGGPepsGGPE-2512-D2133Janoshik2026-Q298.353.66105.2Buyer-sourced0PASS
AX-2026-042731TirzepatideGGPepsGGPE-2604-H1052Janoshik2026-Q299.001.92—Buyer-sourced0PASS
AX-2026-042471EpitalonHomopeptideHOMO-2512-A5108VendorInvestigate2026-Q299.398.0490.0Buyer-sourced0PASS
AX-2026-041890SemaglutideSinoPepSNP-2511-P4283Kestrel2026-Q298.663.6289.6Buyer-sourced1MARGINAL
AX-2026-041761SelankTFSTFS-{CAT}-1712PeptideMeter2026-Q299.937.7991.8Buyer-sourced0PASS
AX-2026-041705BPC-157TFSTFS-{CAT}-9814PeptideMeter2026-Q299.254.5192.1Buyer-sourced0PASS
AX-2026-041688SemaglutideTFSTFS-{CAT}-9744Medutest2026-Q298.175.60—Buyer-sourced0PASS
AX-2026-041666PT-141 (Bremelanotide)FGPFGP-2602-Y8741Janoshik2026-Q299.934.5788.6Buyer-sourced1MARGINAL
AX-2026-041658TirzepatideFGPFGP-2605-R8870PeptideMeter2026-Q297.716.9198.5Buyer-sourced0PASS
AX-2026-043523TirzepatideSIGSIG-2512-6026Janoshik2026-Q297.873.05107.2Buyer-sourced1MARGINAL
AX-2026-043465MGFBCHBCH-2511-D5168Janoshik2026-Q298.595.3699.0Buyer-sourced0PASS
AX-2026-043384MOTS-cWXTWXT-2511-P3368Janoshik2026-Q298.375.6292.1Buyer-sourced2MARGINAL
AX-2026-043002SemaglutideMKMMKM-2601-Y4342Nordanalyt2026-Q298.094.03104.3Buyer-sourced0PASS
AX-2026-041961PT-141 (Bremelanotide)AMBAMB-2601-M5602VendorInvestigate2026-Q299.932.4897.9Buyer-sourced0PASS
AX-2026-041819GHRP-2ASYASY-{CAT}-2426Janoshik2026-Q299.716.84104.4Buyer-sourced0PASS
AX-2026-041754SelankTFSTFS-{CAT}-1712PeptideMeter2026-Q299.937.49—Buyer-sourced0PASS
AX-2026-041617TB-500FGPFGP-2512-Y7789VendorInvestigate2026-Q299.574.4999.6Buyer-sourced0PASS
AX-2026-043579PEG-MGFSIGSIG-2602-6794Janoshik2026-Q297.285.80—Buyer-sourced0PASS
AX-2026-043362L-Glutathione (reduced)WXTWXT-2512-P2820Janoshik2026-Q298.108.92—Buyer-sourced0FAIL
AX-2026-043231ARA-290SGNSGN-2605-X9069VendorInvestigate2026-Q297.807.58—Buyer-sourced0FAIL
AX-2026-043017CJC-1295 (no DAC)MKMMKM-2512-Y4110Medutest2026-Q299.254.8793.6Buyer-sourced0PASS
AX-2026-042952SemaxMKMMKM-2512-B3991Medutest2026-Q298.937.12—Buyer-sourced2FAIL
AX-2026-042417GlucagonHomopeptideHOMO-2602-V3961VendorInvestigate2026-Q299.097.0299.8Buyer-sourced0PASS
AX-2026-042415GlucagonHomopeptideHOMO-2602-V3961VendorInvestigate2026-Q299.596.6597.4Buyer-sourced0PASS
AX-2026-042138PT-141 (Bremelanotide)JEEPJEEP-2601-K8195Medutest2026-Q298.924.36—Buyer-sourced1MARGINAL
AX-2026-041401OxytocinQYBQYB-2601-V4429Janoshik2026-Q299.874.61—Buyer-sourced0PASS
AX-2026-043580PEG-MGFSIGSIG-2602-6794Janoshik2026-Q297.835.5199.3Buyer-sourced0PASS
AX-2026-043011L-Glutathione (reduced)MKMMKM-2602-X4844Nordanalyt2026-Q298.508.9593.4Buyer-sourced1MARGINAL
AX-2026-042762SemaxGGPepsGGPE-2602-Y9952Janoshik2026-Q299.905.48104.4Supplier-supplied0PASS
AX-2026-042592TirzepatideHJHJ-2511-B6617PeptideMeter2026-Q299.016.0590.9Buyer-sourced0PASS
AX-2026-042317Kisspeptin-10TFCTFC-2604-B2419Janoshik2026-Q299.504.2797.3Buyer-sourced0PASS
AX-2026-042312IpamorelinTFCTFC-2603-M2502Nordanalyt2026-Q299.834.39—Buyer-sourced0PASS
AX-2026-041888SemaglutideSinoPepSNP-2511-P4283Medutest2026-Q298.614.12—Buyer-sourced0PASS
AX-2026-041592SemaglutideQSCQSC-2511-M8005Janoshik2026-Q299.473.4497.0Buyer-sourced0PASS
AX-2026-041488CJC-1295 (no DAC)QSCQSC-2601-B6118PeptideMeter2026-Q299.505.46101.4Buyer-sourced1MARGINAL
AX-2026-043659MGFPPGPPG-2512-G7713Nordanalyt2026-Q299.294.41102.5Buyer-sourced0PASS
AX-2026-043251GHK-CuCPCCPC-2601-D1258PeptideMeter2026-Q298.236.25—Supplier-supplied0PASS
AX-2026-043169BPC-157GL BiochemGLBI-2602-T8050Janoshik2026-Q298.784.32—Buyer-sourced1MARGINAL